168 related articles for article (PubMed ID: 36765844)
1. Comparison of Recurrence Patterns between Adenocarcinoma and Squamous Cell Carcinoma after Stereotactic Body Radiotherapy for Early-Stage Lung Cancer.
Kita N; Tomita N; Takaoka T; Sudo S; Tsuzuki Y; Okazaki D; Niwa M; Torii A; Takano S; Niimi A; Hiwatashi A
Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765844
[TBL] [Abstract][Full Text] [Related]
2. Differences between Survival Rates and Patterns of Failure of Patients with Lung Adenocarcinoma and Squamous Cell Carcinoma Who Received Single-Fraction Stereotactic Body Radiotherapy.
Schrand TV; Iovoli AJ; Almeida ND; Yu H; Malik N; Farrugia M; Singh AK
Cancers (Basel); 2024 Feb; 16(4):. PubMed ID: 38398146
[TBL] [Abstract][Full Text] [Related]
3. Stereotactic ablative radiotherapy (SABR) in early stage non-small cell lung cancer: Comparing survival outcomes in adenocarcinoma and squamous cell carcinoma.
Abel S; Hasan S; White R; Schumacher L; Finley G; Colonias A; Wegner RE
Lung Cancer; 2019 Feb; 128():127-133. PubMed ID: 30642444
[TBL] [Abstract][Full Text] [Related]
4. Histology significantly affects recurrence and survival following SBRT for early stage non-small cell lung cancer.
Baine MJ; Verma V; Schonewolf CA; Lin C; Simone CB
Lung Cancer; 2018 Apr; 118():20-26. PubMed ID: 29571997
[TBL] [Abstract][Full Text] [Related]
5. Establishing a histology-specific biologically effective dose threshold for lung stereotactic ablative radiotherapy (SABR): Is ≥100 Gy
Abel S; Hasan S; Verma V; Weksler B; Colonias A; Horne ZD; Wegner RE
Lung Cancer; 2019 Sep; 135():169-174. PubMed ID: 31446991
[TBL] [Abstract][Full Text] [Related]
6. Single Institution Experience of Stereotactic Body Radiation Therapy in Non-small Cell Lung Cancer: Comparison of Two Dose Regimes and a Perspective on Ideal Dose Regimens.
Nittala MR; Duggar WN; Mundra E; Packianathan S; Smith ML; Woods WC; Otts J; Bhandari R; Allbright R; De Delva PE; Moremen JR; Yang CC; Vijayakumar S
Cureus; 2021 Oct; 13(10):e18862. PubMed ID: 34804715
[TBL] [Abstract][Full Text] [Related]
7. A Retrospective Long-term Follow-up Study of Stereotactic Body Radiation Therapy for Non-Small Cell Lung Cancer From a Single Institution: Incidence of Late Local Recurrence.
Shintani T; Matsuo Y; Iizuka Y; Mitsuyoshi T; Mizowaki T
Int J Radiat Oncol Biol Phys; 2018 Apr; 100(5):1228-1236. PubMed ID: 29722662
[TBL] [Abstract][Full Text] [Related]
8. Lobar Gross Endobronchial Disease Predicts for Overall Survival and Grade 5 Pulmonary Toxicity in Medically Inoperable Early Stage Non-Small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy.
Aghdam N; Lischalk JW; Marin MP; Hall C; O'Connor T; Campbell L; Suy S; Collins SP; Margolis M; Krochmal R; Anderson E; Collins BT
Front Oncol; 2021; 11():728519. PubMed ID: 34912703
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological and survival outcomes of 4L lymph node dissection in left lung adenocarcinoma and squamous cell carcinoma.
Shen L; Guo J; Zhang W; Liang C; Chen H; Liu Y
Front Oncol; 2023; 13():1124014. PubMed ID: 37114135
[TBL] [Abstract][Full Text] [Related]
10. [Patterns of recurrence in patients with stage pT3N0M0 thoracic esophageal squamous cell carcinoma after two-field esophagectomy].
Wang Y; Wang L; Yang Q; Li J; He M; Yao J; Qi Z; Li B; Qiao X
Zhonghua Zhong Liu Za Zhi; 2016 Jan; 38(1):48-54. PubMed ID: 26796807
[TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of histology in patients with cervical squamous cell carcinoma, adenocarcinoma and small cell neuroendocrine carcinoma.
Intaraphet S; Kasatpibal N; Siriaunkgul S; Sogaard M; Patumanond J; Khunamornpong S; Chandacham A; Suprasert P
Asian Pac J Cancer Prev; 2013; 14(9):5355-60. PubMed ID: 24175825
[TBL] [Abstract][Full Text] [Related]
12. Clinical Outcomes of Stereotactic Body Radiotherapy for Patients With Stage I Small-Cell Lung Cancer: Analysis of a Subset of the Japanese Radiological Society Multi-Institutional SBRT Study Group Database.
Shioyama Y; Onishi H; Takayama K; Matsuo Y; Takeda A; Yamashita H; Miyakawa A; Murakami N; Aoki M; Matsushita H; Matsumoto Y; Shibamoto Y;
Technol Cancer Res Treat; 2018 Jan; 17():1533033818783904. PubMed ID: 29983096
[TBL] [Abstract][Full Text] [Related]
13. Effect of histology on stereotactic body radiotherapy for non-small cell lung cancer oligometastatic pulmonary lesions.
Allen AJ; Labella DA; Kowalchuk RO; Waters MR; Kersh CR
Transl Lung Cancer Res; 2023 Jan; 12(1):66-78. PubMed ID: 36762063
[TBL] [Abstract][Full Text] [Related]
14. The Prognostic Value of TTF-1/NKX2-1 in Lung Squamous Cell Carcinoma.
Liao Y; Yang F; Li X; Chen K; Wang J
Appl Immunohistochem Mol Morphol; 2023 Jul; 31(6):414-420. PubMed ID: 37338116
[TBL] [Abstract][Full Text] [Related]
15. Comparison of treatment outcomes between squamous cell carcinoma and adenocarcinoma of cervix after definitive radiotherapy or concurrent chemoradiotherapy.
Hu K; Wang W; Liu X; Meng Q; Zhang F
Radiat Oncol; 2018 Dec; 13(1):249. PubMed ID: 30558636
[TBL] [Abstract][Full Text] [Related]
16. Incidental mediastinal dose does not explain low mediastinal node recurrence rates in patients with early-stage NSCLC treated with stereotactic body radiotherapy.
Rwigema JC; Chen AM; Wang PC; Lee JM; Garon E; Lee P
Clin Lung Cancer; 2014 Jul; 15(4):287-93. PubMed ID: 24594401
[TBL] [Abstract][Full Text] [Related]
17. Cervical Adenocarcinoma Has a Poorer Prognosis and a Higher Propensity for Distant Recurrence Than Squamous Cell Carcinoma.
Jung EJ; Byun JM; Kim YN; Lee KB; Sung MS; Kim KT; Jeong DH
Int J Gynecol Cancer; 2017 Jul; 27(6):1228-1236. PubMed ID: 28604449
[TBL] [Abstract][Full Text] [Related]
18. Stereotactic Ablative Radiotherapy for stage I histologically proven non-small cell lung cancer: an Italian multicenter observational study.
Ricardi U; Frezza G; Filippi AR; Badellino S; Levis M; Navarria P; Salvi F; Marcenaro M; Trovò M; Guarneri A; Corvò R; Scorsetti M
Lung Cancer; 2014 Jun; 84(3):248-53. PubMed ID: 24681279
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of the number of the metastatic lymph nodes in locally early-stage cervical cancer: squamous cell carcinoma versus non-squamous cell carcinoma.
Aslan K; Haberal A; Akıllı H; Meydanli MM; Ayhan A
Arch Gynecol Obstet; 2021 Nov; 304(5):1279-1289. PubMed ID: 33772630
[TBL] [Abstract][Full Text] [Related]
20. Comparison of survival outcomes between squamous cell carcinoma and adenocarcinoma/adenosquamous carcinoma of the cervix after radical radiotherapy and chemotherapy.
Liu P; Ji M; Kong Y; Huo Z; Lv Q; Xie Q; Wang D; Chen B; Wang H; Cui Z; Wang Q; Bin X; Lang J; Chen C
BMC Cancer; 2022 Mar; 22(1):326. PubMed ID: 35337279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
